-
Mashup Score: 0Sinaptica Therapeutics obtains FDA Breakthrough Device Designation for Alzheimer's treatment - 2 year(s) ago
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer’s patients.
Source: MobiHealthNewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Phagenesis launches Phagenyx neurostim system in U.S. - 2 year(s) ago
Phagenesis announced yesterday that it received FDA de novo clearance for its Phagenyx neurostimulation system.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0DyAnsys' neurostimulation device receives FDA clearance to treat post-cardiac surgery pain - 2 year(s) ago
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 6FDA approves Abbott's next-gen spinal cord stimulation therapy - 2 year(s) ago
Abbott announced today that the FDA approved its new Proclaim Plus spinal cord stimulation (SCS) system with FlexBurst360.
Source: MassDeviceCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0FDA clears new neurostimulation system for chronic pain - 2 year(s) ago
“With its ability to mimic natural patterns found in the brain, the Abbott BurstDR platform has been a game changer,” said Dr. Steven Falowski.
Source: www.mdedge.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Abbott announced today that it received Health Canada licensing for its NeuroSphere Virtual Clinic, enabling it to launch the app.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3Sinus pain is just the beginning for Tivic Health’s CEO - 2 year(s) ago
Tivic Health CEO Jennifer Ernst thinks the bioelectronic medicine space is ready to explode. The company is starting with its ClearUp device.
Source: Medical Design and OutsourcingCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0MicroTransponder reports first commercial implantation of its stroke rehab neurostim system - 2 year(s) ago
MicroTransponder announced the first commercial implantation of its Vivistim paired VNS system for chronic ischemic stroke rehabilitation.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Microtranspondr reports first commercial implantation of its #stroke rehab #neurostimulation system - Stroke survivors whose hand and arm function have not significantly improved can be assessed to check if they are potential candidates for #Vivistim https://t.co/KDKDdO0e2M https://t.co/dPM1oYw4Gv
-
-
Mashup Score: 0Abbott launches upgraded digital health app for neurostimulation - 2 year(s) ago
Abbott said the latest NeuroSphere myPath digital health app enables doctors to better track their neurostimulation patients’ pain relief.
Source: MassDeviceCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Nevro touts 12-month data for 10 kHz spinal cord stimulation - 2 year(s) ago
Nevro reported positive 12-month data from the Senza-NSRBP randomized controlled trial of its implantable back pain neurostimulation device.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
Sinaptica Therapeutics obtains #FDA #Breakthrough Device Designation for #Alzheimers treatment | #neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients https://t.co/rPoqbpdhUS